What is treatable ?

Three Clinical Trials have been currently completed on 490 patients.  These patients have been treated with RFQMR for Osteoarthritis and Cancer and the results have been very encouraging. The Cytotron System has been cleared regarding the relative safety standards. At this time, several systems are being placed in different countries to provide health services.    

Conditions Treatable with the Cytotron
Initially the Clinical Trials focused on Osteoarthritis and Cancer. As Tissue engineering can be applied to almost every part of the body and treats at the very basic level, the potential applications possible will be :

-   Stimulation of Angiogenic Growth Factor and promoting Coronary and peripheral pro-angiogenesis
-   Osteo-arthritis
-   Relieving pain, and disability due to trauma
-   Carpal tunnel syndrome
-   Osteoporosis
-   Pain management / Fibromyalgia
-   Migraine
-   Diabetes, Diabetic neuropathy
-   Problem wounds healing
-   Tinnitus
-   Drug resistant epilepsy